GeneDx Holdings Corp. (WGSWW)

NASDAQ: WGSWW · Real-Time Price · USD · Warrants
0.0630
-0.0009 (-1.41%)
Jun 6, 2025, 2:31 PM - Market open
-1.41%
Market Cap 1.97B
Revenue (ttm) 330.14M
Net Income (ttm) -38.58M
Shares Out 28.53M
EPS (ttm) -1.41
PE Ratio n/a
Forward PE 54.93
Dividend n/a
Ex-Dividend Date n/a
Volume 86,299
Open 0.0729
Previous Close 0.0639
Day's Range 0.0610 - 0.0729
52-Week Range 0.0202 - 0.3410
Beta 2.01
Analysts n/a
Price Target n/a
Earnings Date Feb 18, 2025

About WGSWW

GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut. [Read more]

Sector Healthcare
Founded 2017
Employees 1,000
Stock Exchange NASDAQ
Ticker Symbol WGSWW
Full Company Profile

Financial Performance

In 2024, GeneDx Holdings's revenue was $305.45 million, an increase of 50.79% compared to the previous year's $202.57 million. Losses were -$52.29 million, -70.25% less than in 2023.

News

There is no news available yet.